Additionally, this reprogramming supports the phenotypic plasticity of cancer cells, enabling transitions between different cellular states, for instance, in breast cancer, overexpression of MYC triggers phenotypic transitions and induces a stem cell-like state [276]. This evidence concerns the gene MYC and cancer.